Syngene International shareholding pattern

SYNGENE

422.2

3.70 (-0.87%)
Last updated on 27 Feb, 2026 | 15:58 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Syngene International Shareholding Pattern

  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

52.68%

Mutual Fund

22.71%

Insurance

2.96%

Foreign Institutional Investors

14.96%

Domestic Institutional Investors

0.17%

Retail

6.51%

Others

0.01%

Total Promoters
MAR '25
52.74%
JUN '25
52.68%
SEP '25
52.68%
DEC '25
52.68%

Summary

For Year 2025-26, Syngene International reports the following shareholding: Total Promoters at 52.68%, Mutual Fund at 22.71%, Insurance at 2.96%, Foreign Institutional Investors at 14.96%, Domestic Institutional Investors at 0.17%, and Retail at 6.51%. This breakdown provides a quick snapshot of ownership distribution for Syngene International in 2025-26.

Syngene International FAQs

As of 03-2026, the promoter shareholding in Syngene International stands at 52.68% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Syngene International is 14.96% and 0.17% respectively.

The retail shareholding of the Syngene International is 6.51%.

Changes in shareholding patterns of Syngene International can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Syngene International are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost